Drugs / TAK-113
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT06195514 | — | colorectal cancer | Takeda | No longer available | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TAK-113 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06195514 ↗ |
| Route | Oral | “TAK-113 5 mg capsules, orally, once daily, in a 3 weeks on/1 week off schedule for each 4-week cycle per treatment guidelines.” NCT06195514 ↗ |